Transmission and prevention: latest news

Transmission and prevention resources

  • Post-exposure prophylaxis (PEP)

    PEP involves taking a 28-day course of anti-HIV drugs, after possible exposure to HIV.Doctors will assess your risk of HIV infection before prescribing PrEP.PEP is available from...

    From: Factsheets

    Information level Level 2
  • HIV and having a baby

    Women living with HIV can give birth without passing on HIV to the baby.Your options for conception will depend on your health and your partner’s...

    From: Factsheets

    Information level Level 2
  • HIV transmission

    The two main ways in which HIV is passed on are unprotected vaginal and anal sex.Condoms, PrEP and HIV treatment are effective ways of preventing...

    From: Factsheets

    Information level Level 2
  • Pre-exposure prophylaxis (PrEP)

    PrEP is highly effective in preventing the sexual transmission of HIV. For PrEP to work well, it’s important to take the pills regularly.While PrEP can...

    From: Factsheets

    Information level Level 2
  • Viral load and transmission – a factsheet for HIV-negative people

    People with HIV who are on treatment and have an undetectable viral load are extremely unlikely to pass on HIV.Large scientific studies have proven this.Not...

    From: Factsheets

    Information level Level 2
  • Viral load and transmission – a factsheet for people with HIV

    Effective HIV treatment reduces the amount of HIV in your body fluids.Having an undetectable viral load greatly reduces your chance of passing HIV on to...

    From: Factsheets

    Information level Level 2
  • PrEP

    This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing...

    From: HIV prevention briefing papers

  • Sex and HIV

    Sex, desire and pleasure need not stop when you have an HIV diagnosis. Women continue to be sexually active and to have fulfilling sexual and emotional relationships. Many...

    From: Booklets

    Information level Level 2
  • Sex

    Having HIV can affect people’s feelings about sex in many different ways. Some people become anxious about passing HIV on, or feel less desirable. While some people go...

    From: Booklets

    Information level Level 2
  • Transmission of drug-resistant virus

    Some people contract HIV that is already resistant to one or more anti-HIV drugs (this has been the case for between 6 and 10% of people in...

    From: Booklets

    Information level Level 2
  • HIV treatment as prevention

    This briefing paper, produced by NAM for HIV Prevention England, describes the scientific evidence for HIV treatment as prevention and considers its implications for the UK....

    From: HIV prevention briefing papers

  • Undiagnosed HIV infection

    This briefing paper, produced by NAM for HIV Prevention England, covers undiagnosed HIV infection and late diagnosis of HIV in the UK....

    From: HIV prevention briefing papers

  • Oral sex

    Many people enjoy giving and receiving oral sex – kissing, licking or sucking another person’s genitals.The risk of getting HIV from performing oral sex on someone with HIV...

    From: Factsheets

    Information level Level 2
  • Bacterial vaginosis

    Bacterial vaginosis is a common condition which occurs when the balance of bacteria in the vagina becomes disrupted. Symptoms include changes to vaginal discharge and a fishy smell.Having...

    From: Factsheets

    Information level Level 2
  • Transmission and viral load

    There is less risk of passing on HIV if your viral load is undetectable because you are taking anti-HIV drugs. Not all scientists agree on...

    From: The basics

    Information level Level 1
  • Behaviour change

    A practical introduction to the evidence regarding the effectiveness of non-biomedical HIV prevention methods....

    From: Preventing HIV

    Information level Level 4
  • Post-exposure prophylaxis

    Post-exposure prophylaxis (PEP) has been in use, in healthcare settings, since 1988. Providing PEP after sexual exposure is more controversial....

    From: Preventing HIV

    Information level Level 4
  • Pre-exposure prophylaxis

    Pre-exposure prophylaxis is an experimental HIV-prevention strategy that would use antiretrovirals (ARVs) to protect HIV-negative people from HIV infection....

    From: Preventing HIV

    Information level Level 4
  • Microbicides

    Microbicides are any substances which protect people against infection by microbes, such as viruses or bacteria, on contact with those microbes....

    From: Preventing HIV

    Information level Level 4
  • Preventing HIV

    An essential resource providing evidence-based information on preventing HIV infection. ...

    From: Aidsmap 2.0

    Information level Level 4
  • Risk

    An examination of prosecuted behaviours, using scientific evidence to determine actual risk, and how this evidence has been applied in jurisdictions worldwide....

    From: HIV & the criminal law

    Information level Level 4
  • HIV transmission & testing

    A practical guide to the complexities surrounding HIV transmission routes, risks and HIV testing. ...

    From: Aidsmap 2.0

    Information level Level 4

Transmission and prevention features

Transmission and prevention in your own words

  • Bored and horny

    It’s Sunday afternoon and it’s raining. I’m bored and horny. However, I’ve got £20 left over from the night before and this will be enough...

    From: In your own words

Transmission and prevention news from aidsmap

More news

Transmission and prevention news selected from other sources

  • PrEP, test-and-treat offer most cost-effective methods for HIV prevention

    Pre-exposure prophylaxis, or PrEP, and “test-and-treat” methods are both more cost-effective than the current strategy for the prevention of HIV transmission among men who have sex with men, according to researchers. The success of either strategy, however, depends on treatment initiation and adherence.

    19 September 2016 | Healio
  • Why some organizations are slow to adopt the undetectable = uninfectious message

    We need to somehow get a grip on what these messages mean for people, and the implications of our messaging. That, I think, will involve some reflection on how we use and interpret scientific findings and our comfort levels with risk.

    06 September 2016 | Positive Lite
  • World’s Largest Drug Consumption Room Opens in Copenhagen

    The world’s largest drug consumption room (DCR) has opened in Copenhagen, offering a safe and supervised environment for people to use illicit drugs.

    16 August 2016 | Talking Drugs
  • The end of the end of AIDS

    The Durban 2016 AIDS Conference marks the end of "ending the HIV epidemic" as a feasible goal with the tools we have. We need new and better tools. Talk of ending AIDS has led to a widespread perception in the broader health and development community that this crisis is over. It isn't.

    16 August 2016 | World Bank (blog)
  • HIV/AIDS: Filarial worm infections double the risk of infection

    Since the start of the HIV epidemic, there have been speculations as to why HIV and the immunodeficiency syndrome it causes have spread so much more in Africa than in other countries around the world. Scientists have now, for the first time, confirmed one reason for this: in a cohort study conducted in Tanzania, they discovered that an infection with the filarial nematode Wuchereria bancrofti increases the risk of HIV infection by two to three fold.

    16 August 2016 | Eurekalert Inf Dis
  • Are we 'Generation Bareback'?

    Recent studies show an increase in unprotected sex amongst HIV-negative gay men. Why are some of us ditching condoms? And in a world of treatment, undetectability and PrEP, is this the start of generation bareback?

    15 August 2016 | FS
  • Read about how the Daily Mail is lying to you about PrEP

    Promiscuous English gay men who want PrEP are taking life-saving drugs from the mouths of cancer patients and condemning older people to blindness. What total crap. But that's the very clear message you will get if you read The Daily Mail or The Times today.

    03 August 2016 | Gay Star News
  • HIV is back on the front pages

    At The King's Fund, we have argued for empowering local services to reform from within rather than relying on top-down direction, regulation or market forces to deliver high-quality care. The dispute over the funding of antiretroviral drugs for prevention illustrates the challenges of doing this in the absence of an effective strategic and integrated approach to commissioning, especially when the structures are so complex and the relationship between local decisions and national strategy so loosely defined.

    03 August 2016 | The King's Fund
  • Historic win for NAT as the High Court overturns NHS England refusal to consider PrEP

    NAT (National AIDS Trust) is delighted by the judgment passed down in the High Court today that NHS England acted unlawfully in withdrawing PrEP, a game-changing drug preventing transmission of HIV, from its decision-making process.

    02 August 2016 | NAT (National AIDS Trust)
  • People At High Risk Of HIV Are Having The HIV Prevention Pill Taken From Them

    Exclusive: The NHS is stopping participants in a major study into the drug Truvada from having further access to it – a move which Britain’s biggest HIV charity said would lead some to become infected.

    29 July 2016 | Buzzfeed
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close